U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H13N5O4
Molecular Weight 267.2413
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2'-DEOXYGUANOSINE

SMILES

NC1=NC2=C(N=CN2[C@H]3C[C@H](O)[C@@H](CO)O3)C(=O)N1

InChI

InChIKey=YKBGVTZYEHREMT-KVQBGUIXSA-N
InChI=1S/C10H13N5O4/c11-10-13-8-7(9(18)14-10)12-3-15(8)6-1-4(17)5(2-16)19-6/h3-6,16-17H,1-2H2,(H3,11,13,14,18)/t4-,5+,6+/m0/s1

HIDE SMILES / InChI
Deoxyguanosine is a nucleoside consisting of the base guanine and the sugar deoxyribose. It is like guanosine, but with one oxygen atom removed. It is a nucleoside component of DNA. Deoxyguanosine can be converted to 8-hydroxy-deoxyguanosine (8-OHdG) due to hydroxyl radical attack at the C8 of guanine. 8-OHdG is a sensitive marker of the DNA damage This damage, if left unrepaired, has been proposed to contribute to mutagenicity and cancer promotion. Deoxyguanosine has long been recognized as a potent cytotoxic agent to cultured mammalian cells. This toxicity or inhibition of DNA synthesis by deoxyguanosine appears to be mediated by deoxyguanosine triphosphate-mediated inhibition of the enzyme ribonucleotide reductase. Purine nucleoside phosphorylase deficiency is thought to cause T-lymphocyte depletion by accumulation of deoxyguanosine and deoxyguanosine triphosphate, resulting in feedback inhibition of ribonucleotide reductase and hence DNA synthesis. Deoxyguanosine nucleoside analogs are potent antiviral agents.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: Q16854
Gene ID: 1716.0
Gene Symbol: DGUOK
Target Organism: Homo sapiens (Human)
Target ID: P00491
Gene ID: 4860.0
Gene Symbol: PNP
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Apoptosis induces efflux of the mitochondrial matrix enzyme deoxyguanosine kinase.
2001-06-29
Benzo(a)pyrene-coated onto Fe(2)O(3) particles-induced lung tissue injury: role of free radicals.
2001-06-10
Enhancement of OGG1 protein AP lyase activity by increase of APEX protein.
2001-06-05
Bioactivation of tamoxifen to metabolite E quinone methide: reaction with glutathione and DNA.
2001-06
Effects of a Brussels sprouts extract on oxidative DNA damage and metabolising enzymes in rat liver.
2001-06
The C(8)-(2'-deoxy-beta-D-ribofuranoside) of 7-deazaguanine: synthesis and base pairing of oligonucleotides with unusually linked nucleobases.
2001-05-18
Mechanism of lower genotoxicity of toremifene compared with tamoxifen.
2001-05-15
A new murine oxidative stress model associated with senescence.
2001-05-15
Oxidation of thymine to 5-formyluracil in DNA promotes misincorporation of dGMP and subsequent elongation of a mismatched primer terminus by DNA polymerase.
2001-05-11
Observation and elimination of N-acetylation of oligonucleotides prepared using fast-deprotecting phosphoramidites and ultra-mild deprotection.
2001-05-07
Hepatocellular oxidative DNA injury induced by macrophage-derived nitric oxide.
2001-05-01
Catechol estrogens induce oxidative DNA damage and estradiol enhances cell proliferation.
2001-05-01
Acute hypoxia and hypoxic exercise induce DNA strand breaks and oxidative DNA damage in humans.
2001-05
Hydrogen peroxide: effects on DNA, chromosomes, cell cycle and apoptosis induction in Fanconi's anemia cell lines.
2001-05
Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters.
2001-05
Superoxide dismutases enhance H2O2-induced DNA damage and alter its site specificity.
2001-04-27
Maternal genetic effects on neonatal susceptibility to oxidative damage from environmental tobacco smoke.
2001-04-18
Efficient methods for the synthesis of [2-15N]guanosine and 2'-deoxy[2-15N]guanosine derivatives.
2001-04-17
Enhanced nucleophilicity and depressed electrophilicity of peroxide by zinc(II), aluminum(III) and lanthanum(III) ions.
2001-04-17
Site-specific DNA damage at the GGG sequence by UVA involves acceleration of telomere shortening.
2001-04-17
DNA repair and aging in mouse liver: 8-oxodG glycosylase activity increase in mitochondrial but not in nuclear extracts.
2001-04-15
Analysis of enzyme kinetics using electrospray ionization mass spectrometry and multiple reaction monitoring: fucosyltransferase V.
2001-04-03
Urinary 8-oxo-7, 8-dihydro-2'-deoxyguanosine and biopyrrins levels among construction workers with asbestos exposure history.
2001-04
Docosahexaenoic acid supplementation-increased oxidative damage in bone marrow DNA in aged rats and its relation to antioxidant vitamins.
2001-04
Possible cause of G-C-->C-G transversion mutation by guanine oxidation product, imidazolone.
2001-04
Levels of malondialdehyde-deoxyguanosine in the gastric mucosa: relationship with lipid peroxidation, ascorbic acid, and Helicobacter pylori.
2001-04
Analysis of peroxynitrite reactions with guanine, xanthine, and adenine nucleosides by high-pressure liquid chromatography with electrochemical detection: C8-nitration and -oxidation.
2001-04
Accumulation of 8-oxo-2'-deoxyguanosine and increased expression of hMTH1 protein in brain tumors.
2001-04
Oxidative stress in chemoprevention trials.
2001-04
Nucleotide synthesis via methods without nucleoside-base protection.
2001-04
Induction of direct adducts, apurinic/apyrimidinic sites and oxidized bases in nuclear DNA of human HeLa S3 tumor cells by tetrachlorohydroquinone.
2001-04
Oxidative damage and direct adducts in calf thymus DNA induced by the pentachlorophenol metabolites, tetrachlorohydroquinone and tetrachloro-1,4-benzoquinone.
2001-04
Influence of flanking sequence context on the mutagenicity of acetylaminofluorene-derived DNA adducts in mammalian cells.
2001-03-27
Protein and DNA oxidation in spinal injury: neurofilaments--an oxidation target.
2001-03-15
1,N(2)-propanodeoxyguanosine adduct formation in aortic DNA following inhalation of acrolein.
2001-03
The relation of oxidative DNA damage to hypertension and other cardiovascular risk factors in Tanzania.
2001-03
Relationships between perceived workload, stress and oxidative DNA damage.
2001-03
Pulmonary carcinogenesis induced by ferric nitrilotriacetate in mice and protection from it by Brazilian propolis and artepillin C.
2001-03
Active intestinal absorption of nucleosides by Na+-dependent transport across the brush border membrane in cows.
2001-03
Analysis of fluoroquinolone-mediated photosensitization of 2'-deoxyguanosine, calf thymus and cellular DNA: determination of type-I, type-II and triplet-triplet energy transfer mechanism contribution.
2001-03
HU binding to DNA: evidence for multiple complex formation and DNA bending.
2001-02-27
Effects of benzo[a]pyrene DNA adducts on Escherichia coli DNA polymerase I (Klenow fragment) primer-template interactions: evidence for inhibition of the catalytically active ternary complex formation.
2001-02-20
Eosinophil peroxidase catalyzes bromination of free nucleosides and double-stranded DNA.
2001-02-20
The effect of dietary carotenoids on lung tumorigenesis induced by intratracheally instillated diesel exhaust particles.
2001-02
Melatonin prevents delta-aminolevulinic acid-induced oxidative DNA damage in the presence of Fe2+.
2001-02
Interaction of Escherichia coli purine nucleoside phosphorylase (PNP) with the cationic and zwitterionic forms of the fluorescent substrate N(7)-methylguanosine.
2001-01-12
Antitumor efficacy of SarCNU in a human glioma xenograft model expressing both MGMT and extraneuronal monoamine transporter.
2001-01
The role of duck hepatitis B virus and aflatoxin B1 in the induction of oxidative stress in the liver.
2001
Gene- and tissue-specificity of mutation in Big Blue rats treated with the hepatocarcinogen N-hydroxy-2-acetylaminofluorene.
2001
Comparison of iron-catalyzed DNA and lipid oxidation.
2001
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
2'-deoxyguanosine toxicity for T lymphoblasts is markedly potentiated by 8-aminoguanosine and is mediated by the accumulation of deoxyguanosine triphosphate. In contrast, the growth of T4+ mature T cell lines and B lymphoblast cell lines is inhibited by somewhat higher concentrations of 2'-deoxyguanosine (ID50 20 and 18 microM, respectively) in the presence of 8-aminoguanosine without an increase in deoxyguanosine triphosphate levels. Cytotoxicity correlates instead with a three- to fivefold increase in guanosine triphosphate (GTP) levels after 24 h. Accumulation of GTP and growth inhibition also result from exposure to guanosine, but not to guanine at equimolar concentrations. B lymphoblasts which are deficient in the purine salvage enzyme hypoxanthine guanine phosphoribosyltransferase are completely resistant to 2'-deoxyguanosine or guanosine concentrations up to 800 microM and do not demonstrate an increase in GTP levels.
Name Type Language
2'-DEOXYGUANOSINE
Systematic Name English
NSC-22837
Preferred Name English
9-(2-DEOXY-.BETA.-D-ERYTHRO-PENTOFURANOSYL)GUANINE
Common Name English
GUANOSINE, 2'-DEOXY-
Systematic Name English
DEOXYGUANOSINE
Systematic Name English
2'-DESOXYGUANOSINE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C707
Created by admin on Mon Mar 31 17:48:09 GMT 2025 , Edited by admin on Mon Mar 31 17:48:09 GMT 2025
LOINC 75149-5
Created by admin on Mon Mar 31 17:48:09 GMT 2025 , Edited by admin on Mon Mar 31 17:48:09 GMT 2025
LOINC 59201-4
Created by admin on Mon Mar 31 17:48:09 GMT 2025 , Edited by admin on Mon Mar 31 17:48:09 GMT 2025
LOINC 75134-7
Created by admin on Mon Mar 31 17:48:09 GMT 2025 , Edited by admin on Mon Mar 31 17:48:09 GMT 2025
Code System Code Type Description
PUBCHEM
135398592
Created by admin on Mon Mar 31 17:48:09 GMT 2025 , Edited by admin on Mon Mar 31 17:48:09 GMT 2025
PRIMARY
WIKIPEDIA
Deoxyguanosine
Created by admin on Mon Mar 31 17:48:09 GMT 2025 , Edited by admin on Mon Mar 31 17:48:09 GMT 2025
PRIMARY
CAS
961-07-9
Created by admin on Mon Mar 31 17:48:09 GMT 2025 , Edited by admin on Mon Mar 31 17:48:09 GMT 2025
PRIMARY
NCI_THESAURUS
C421
Created by admin on Mon Mar 31 17:48:09 GMT 2025 , Edited by admin on Mon Mar 31 17:48:09 GMT 2025
PRIMARY NCIT
NSC
22837
Created by admin on Mon Mar 31 17:48:09 GMT 2025 , Edited by admin on Mon Mar 31 17:48:09 GMT 2025
PRIMARY
EVMPD
SUB197050
Created by admin on Mon Mar 31 17:48:09 GMT 2025 , Edited by admin on Mon Mar 31 17:48:09 GMT 2025
PRIMARY
ECHA (EC/EINECS)
213-505-8
Created by admin on Mon Mar 31 17:48:09 GMT 2025 , Edited by admin on Mon Mar 31 17:48:09 GMT 2025
PRIMARY
SMS_ID
100000182770
Created by admin on Mon Mar 31 17:48:09 GMT 2025 , Edited by admin on Mon Mar 31 17:48:09 GMT 2025
PRIMARY
CHEBI
17172
Created by admin on Mon Mar 31 17:48:09 GMT 2025 , Edited by admin on Mon Mar 31 17:48:09 GMT 2025
PRIMARY
FDA UNII
G9481N71RO
Created by admin on Mon Mar 31 17:48:09 GMT 2025 , Edited by admin on Mon Mar 31 17:48:09 GMT 2025
PRIMARY
EPA CompTox
DTXSID30883626
Created by admin on Mon Mar 31 17:48:09 GMT 2025 , Edited by admin on Mon Mar 31 17:48:09 GMT 2025
PRIMARY